Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
---|---|---|---|---|---|---|---|---|
Feb 13, 2025 | Feb 14, 2025 | Benevich Eric Chief Commercial Officer | Sell | Neurocrine Biosciences Inc | NBIX | $116.73 | $251,428 | -4.60% |
Feb 10, 2025 | Feb 12, 2025 | Benevich Eric Chief Commercial Officer | Sell | Neurocrine Biosciences Inc | NBIX | $118.31 | $115,940 | -2.24% |
Jan 31, 2025 | Feb 04, 2025 | Benevich Eric Chief Commercial Officer | Sell | Neurocrine Biosciences Inc | NBIX | $152.94 | $184,599 | -2.80% |
Apr 15, 2024 | Apr 17, 2024 | Benevich Eric Chief Commercial Officer | Sell | Neurocrine Biosciences Inc | NBIX | $133.37 | $3M | -32.71% |
Mar 14, 2024 | Mar 15, 2024 | Benevich Eric Chief Commercial Officer | Sell | Neurocrine Biosciences Inc | NBIX | $139.38 | $10M | -64.78% |
Feb 28, 2024 | Feb 29, 2024 | Benevich Eric Chief Commercial Officer | Sell | Neurocrine Biosciences Inc | NBIX | $134.69 | $10M | -64.87% |
Feb 13, 2024 | Feb 15, 2024 | Benevich Eric Chief Commercial Officer | Sell | Neurocrine Biosciences Inc | NBIX | $133.02 | $146,050 | -2.63% |
Feb 06, 2024 | Feb 09, 2024 | Benevich Eric Chief Commercial Officer | Sell | Neurocrine Biosciences Inc | NBIX | $138.68 | $313,419 | -5.39% |
Jan 31, 2024 | Feb 03, 2024 | Benevich Eric Chief Commercial Officer | Sell | Neurocrine Biosciences Inc | NBIX | $140.78 | $169,927 | -3.11% |
Aug 21, 2023 | Aug 23, 2023 | Benevich Eric Chief Commercial Officer | Sell | Neurocrine Biosciences Inc | NBIX | $107.4 | $171,836 | -4.21% |
Feb 06, 2023 | Feb 09, 2023 | Benevich Eric Chief Commercial Officer | Sell | Neurocrine Biosciences Inc | NBIX | $102.7 | $2M | -36.37% |
Jan 31, 2023 | Feb 02, 2023 | Benevich Eric Chief Commercial Officer | Sell | Neurocrine Biosciences Inc | NBIX | $109.95 | $132,710 | -6.73% |
Jan 06, 2023 | Jan 10, 2023 | Benevich Eric Chief Commercial Officer | Sell | Neurocrine Biosciences Inc | NBIX | $125 | $50,000 | -2.49% |
Nov 30, 2022 | Dec 01, 2022 | Benevich Eric Chief Commercial Officer | Sell | Neurocrine Biosciences Inc | NBIX | $125.9 | $6M | -76.17% |
Nov 08, 2022 | Nov 10, 2022 | Benevich Eric Chief Commercial Officer | Sell | Neurocrine Biosciences Inc | NBIX | $125.33 | $3M | -61.22% |
Nov 02, 2022 | Nov 04, 2022 | Benevich Eric Chief Commercial Officer | Sell | Neurocrine Biosciences Inc | NBIX | $125.02 | $1M | -37.46% |
Oct 17, 2022 | Oct 19, 2022 | Benevich Eric Chief Commercial Officer | Sell | Neurocrine Biosciences Inc | NBIX | $110.82 | $549,682 | -24.07% |
Feb 07, 2022 | Feb 09, 2022 | Benevich Eric Chief Commercial Officer | Sell | Neurocrine Biosciences Inc | NBIX | $80.57 | $410,821 | -20.05% |
Aug 16, 2021 | Aug 18, 2021 | Benevich Eric Chief Commercial Officer | Sell | Neurocrine Biosciences Inc | NBIX | $89.62 | $504,395 | -26.50% |
Feb 05, 2021 | Feb 10, 2021 | Benevich Eric Chief Commercial Officer | Sell | Neurocrine Biosciences Inc | NBIX | $116.38 | $591,089 | -19.40% |
Jan 25, 2021 | Jan 28, 2021 | Benevich Eric Chief Commercial Officer | Sell | Neurocrine Biosciences Inc | NBIX | $120.02 | $657,371 | -25.86% |
Nov 12, 2020 | Nov 16, 2020 | Benevich Eric Chief Commercial Officer | Sell | Neurocrine Biosciences Inc | NBIX | $90.71 | $204,723 | -11.48% |
Nov 02, 2020 | Nov 04, 2020 | Benevich Eric Chief Commercial Officer | Sell | Neurocrine Biosciences Inc | NBIX | $96.53 | $2M | -57.26% |
Aug 05, 2020 | Aug 07, 2020 | Benevich Eric Chief Commercial Officer | Sell | Neurocrine Biosciences Inc | NBIX | $118.85 | $268,254 | -12.80% |
Apr 24, 2020 | Apr 29, 2020 | Benevich Eric Chief Commercial Officer | Sell | Neurocrine Biosciences Inc | NBIX | $99.45 | $192,338 | -12.66% |
Apr 15, 2020 | Apr 18, 2020 | Benevich Eric Chief Commercial Officer | Sell | Neurocrine Biosciences Inc | NBIX | $94.65 | $817,018 | -42.66% |
Feb 07, 2020 | Feb 12, 2020 | Benevich Eric Chief Commercial Officer | Sell | Neurocrine Biosciences Inc | NBIX | $103.32 | $209,747 | -9.18% |
Feb 05, 2020 | Feb 07, 2020 | Benevich Eric Chief Commercial Officer | Sell | Neurocrine Biosciences Inc | NBIX | $102.38 | $342,872 | -15.50% |
Jul 15, 2019 | Jul 17, 2019 | Benevich Eric Chief Commercial Officer | Sell | Neurocrine Biosciences Inc | NBIX | $87.44 | $510,201 | -28.13% |
Feb 06, 2019 | Feb 08, 2019 | Benevich Eric Chief Commercial Officer | Sell | Neurocrine Biosciences Inc | NBIX | $83.57 | $76,883 | -4.25% |